Hepatic glucokinase promoter polymorphism is associated with hepatic insulin resistance in Asian Indians

被引：37

作者：

Chiu K.C. ^{[1
]}

Chuang L.-M. ^{[1
,2
]}

Yoon C. ^{[1
,2
]}

Saad M.F. ^{[1
,2
]}

机构：

[1] Div. Endicronol. Diabet./Hypertens., Department of Medicine, University of California, Los Angeles, CA

[2] Department of Internal Medicine, Grad. Inst. of Clinical Medicine, National Taiwan University Hospital, Taipei

来源：

BMC Genetics | / 1卷 / 1期

关键词：

Insulin Sensitivity; Beta Cell; Oral Glucose Tolerance Test; Beta Cell Function; Plasma Glucose Concentration;

D O I：

10.1186/1471-2156-1-2

中图分类号：

学科分类号：

摘要：

Background: The role of glucokinase (GCK) in the pathogenesis of maturity-onset diabetes of the young is well established. However, its role in the common form of type 2 diabetes is far from convincing. We investigated the role of the G-to-A polymorphism in the hepatic GCK promoter on insulin sensitivity and beta cell function in 63 normotensive Asian Indians with normal glucose tolerance. As proposed by Matsuda and DeFronzo, hepatic insulin sensitivity (ISIH) and total body insulin sensitivity (ISIM) were estimated from the oral glucose tolerance test. Beta cell function was estimated using %B from the Homeostasis Model Assessment and insulingenic index (dI/dG). Result: We identified 38 GG, 24 GA, and one AA subjects. The AA subject was pooled with the GA subjects during the analysis. No difference was noted in the demographic features between the two genotypic groups (GG vs. GA/AA). Compared to the GG group, the GA/AA group had a lower ISIH (p=0.002), a lower ISIM (p=0.009), a higher %B (p=0.014), and a higher dI/dG (p=0.030). Multivariate analysis revealed that this polymorphism is an independent determinant for ISIH (p=0.019) and along with age, waist-hip ratio, gender, and diastolic blood pressure accounted for 51.5% of the variation of ISIH. However, this polymorphism was a weak, but independent determinant for ISIM (p=0.089) and %B (p=0.083). Furthermore, it had no independent effect on dI/dG (p=0.135). Conclusions: These data suggest that the G-to-A polymorphism in the hepatic GCK promoter is associated with hepatic insulin resistance in Asian Indians.

引用

共 21 条

[1]

Matschinsky F.M., Glucokinase as glucose sensor and metabolic signal generator in pancreatic beta-cells and hepatocytes, Diabetes, 39, pp. 647-652, (1990)

[2]

Hattersley A.T., Turner R.C., Permutt M.A., Patel P., Tanizawa Y., Chiu K.C., O'Rahilly S., Watkins P.J., Wainscoat J.S., Linkage of type 2 diabetes to the glucokinase gene, Lancet, 339, pp. 1307-1310, (1992)

[3]

Froguel P., Zouali H., Vionnet N., Velho G., Vaxillaire M., Sun F., Lesage S., Stoffer M., Takeda J., Passa P., Et al., Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus, N. Engl. J. Med., 328, pp. 697-702, (1993)

[4]

Chiu K.C., Tanizawa Y., Permutt M.A., Glucokinase gene variants in the common form of NIDDM, Diabetes, 42, pp. 579-582, (1993)

[5]

Caro J.F., Triester S., Patel V.K., Tapscott E.B., Frazier N.L., Dohm G.L., Liver glucokinase: Decreased activity in patients with type II diabetes, Horm. Metab. Res., 27, pp. 19-22, (1995)

[6]

Brichard S.M., Henquin J.C., Girard J., Phlorizin treatment of diabetic rats partially reverses the abnormal expression of genes involved in hepatic glucose metabolism, Diabetologia, 36, pp. 292-298, (1993)

[7]

Chiu K.C., Go R.C., Aoki M., Riggs A.C., Tanizawa Y., Acton R.T., Bell D.S., Goldenberg R.L., Roseman J.M., Permutt M.A., Glucokinase gene in gestational diabetes mellitus: Population association study and molecular scanning, Diabetologia, 37, pp. 104-110, (1994)

[8]

Tanizawa Y., Matsutani A., Chiu K.C., Permutt M.A., Human glucokinase gene: Isolation, structural characterization, and identification of a microsatellite repeat polymorphism, Mol. Endocrinol., 6, pp. 1070-1081, (1992)

[9]

Magnuson M.A., Andreone T.L., Printz R.L., Koch S., Granner D.K., Rat glucokinase gene: Structure and regulation by insulin, Proc. Natl. Acad. Sci. U S A, 86, pp. 4838-4842, (1989)

[10]

O'Brien R.M., Lucas P.C., Forest C.D., Magnuson M.A., Granner D.K., Identification of a sequence in the PEPCK gene that mediates a negative effect of insulin on transcription, Science, 249, pp. 533-537, (1990)

← 1 2 3 →